placeholder image
A. B. Mendelsohn All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Patient characteristics and use for bevacizumab in ophthalmology and oncology in a distributed research network. 
    Journal of managed care & specialty pharmacy. 2025
  • Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States. 
    Journal of managed care & specialty pharmacy. 2024
  • Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm. 
    Journal of Medical Economics. 2023
  • Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis. 
    BMC Musculoskeletal Disorders. 2022
  • Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus. 
    BMJ open diabetes research & care. 2022
  • Patient characteristics and utilization patterns of short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilars compared to their reference product. 
    Drugs - real world outcomes. 2021
    • Contact
    full name
  • A. B. Mendelsohn
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration